Literature DB >> 14331621

TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.

R M JAMESON.   

Abstract

Entities:  

Keywords:  ANTI-INFECTIVE AGENTS; DRUG THERAPY; ESCHERICHIA COLI INFECTIONS; NALIDIXIC ACID; NAPHTHYRIDINES; PROTEUS INFECTIONS; PYELONEPHRITIS

Mesh:

Substances:

Year:  1965        PMID: 14331621      PMCID: PMC1846050          DOI: 10.1136/bmj.2.5462.621

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  6 in total

1.  ABSORPTION, EXCRETION, AND METABOLISM OF A NEW ANTIBACTERIAL AGENT, NALIDIXIC ACID.

Authors:  E W MCCHESNEY; E J FROELICH; G Y LESHER; A V CRAIN; D ROSI
Journal:  Toxicol Appl Pharmacol       Date:  1964-05       Impact factor: 4.219

2.  CXCVII. NALIDIXIC ACID.

Authors:  J SWINNEY
Journal:  Practitioner       Date:  1964-05

3.  NALIDIXIC ACID IN URINARY INFECTIONS.

Authors:  J F WARD-MCQUAID; D JICHLINSKI; R MACIS
Journal:  Br Med J       Date:  1963-11-23

4.  NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.

Authors:  A M BARLOW
Journal:  Br Med J       Date:  1963-11-23

5.  A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.

Authors:  R M JAMESON; J SWINNEY
Journal:  Br J Urol       Date:  1963-06

6.  Pyelonephritis.

Authors:  J U SCHLEGEL
Journal:  J Ark Med Soc       Date:  1962-11
  6 in total
  3 in total

1.  Distribution of gentamicin in body fluids.

Authors:  G D Chisholm; J S Calnan; P M Waterworth; N D Reis
Journal:  Br Med J       Date:  1968-04-06

2.  Effect of renal excretion rate on intrarenal distribution of sulfonamides.

Authors:  P Silva; M L Macia; J Torretti
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

3.  Comparative efficacy and safety of nalidixic acid versus trimethoprim/sulfamethoxazole in treatment of acute urinary tract infections in college-age women.

Authors:  A Iravani; G A Richard; H Baer; R Fennell
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.